Macrophage migration inhibitory factor (MIF) enhances palmitic acid- and glucose-induced murine beta cell dysfunction and destruction in vitro

References

• Bell GI, Polonsky KS. 2001. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature. 414:788–791.
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol. 3:791–800.
   PubMed Web of Science ®Google Scholar
• Cvetkovic I, Al-Abed Y, Miljkovic D, Maksimovic-Ivanic D, Roth J, Bacher M, Lan HY, Nicoletti F, Stosic-Grujicic S. 2005. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology. 146:2942–2951.
   Google Scholar
• Cvetkovic I, Stosic-Grujicic S. 2006. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol. 6:1527–1534.
   PubMed Web of Science ®Google Scholar
• Cvjetićanin T, Stojanović I, Timotijević G, Stosić-Grujicić S, Miljković D. 2009. T cells cooperate with palmitic acid in induction of beta cell apoptosis. BMC Immunol. 10:29–39.
   Google Scholar
• Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol. 144:891–901.
   PubMed Web of Science ®Google Scholar
• Dhanantwari P, Nadaraj S, Kenessey A, Chowdhury D, Al-Abed Y, Miller EJ, Ojamaa K. 2008. Macrophage migration inhibitory factor induces cardiomyocyte apoptosis. Biochem Biophys Res Commun. 371:298–303.
   Google Scholar
• Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA. 2008. Islet inflammation in type 2 diabetes: From metabolic stress to therapy. Diabetes Care. 31:161–164.
   PubMed Web of Science ®Google Scholar
• Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP. 1999. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes. 48:1995–2000.
   PubMed Web of Science ®Google Scholar
• Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE. 2006. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: Results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care. 29:368–371.
   PubMed Web of Science ®Google Scholar
• Ishihara H, Asano T, Tsukuda K, Katagiri H, Inukai K, Anai M, Kikuchi M, Yazaki Y, Miyazaki JI, Oka Y. 1993. Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia. 36:1139–1145.
   PubMed Web of Science ®Google Scholar
• Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, Nikolajczyk BS. 2011. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol. 186:1162–1172.
   PubMed Web of Science ®Google Scholar
• Kahn SE. 2003. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 46:3–19.
   PubMed Web of Science ®Google Scholar
• Lue H, Dewor M, Leng L, Bucala R, Bernhagen J. 2011. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal. 23:135–144.
   PubMed Web of Science ®Google Scholar
• Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patané G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P. 2002. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes. 51:1437–1442.
   PubMed Web of Science ®Google Scholar
• Maedler K. 2008. Beta cells in type 2 diabetes—A crucial contribution to pathogenesis. Diabetes Obes Metab. 10:408–420.
   PubMed Web of Science ®Google Scholar
• Maestre I, Jordan J, Calvo S, Reig JA, Ceña V, Soria B, Prentki M, Roche E. 2003. Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology. 144:335–345.
   PubMed Web of Science ®Google Scholar
• McCarthy MI, Hattersley AT. 2008. Learning from molecular genetics: Novel insights arising from the definition of genes for monogenic and type 2 diabetes. Diabetes. 57:2889–2898.
   PubMed Web of Science ®Google Scholar
• Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K. 1990. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology. 127:126–132.
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med. 2012 2:a007724.
   Google Scholar
• Olefsky J, Glass C. 2010. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 72:1–28.
   Google Scholar
• Olson LK, Redmon JB, Towle HC, Robertson RP. 1993. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest. 92:514–519.
   PubMed Web of Science ®Google Scholar
• Pfützner A, Schöndorf T, Hanefeld M, Forst T. 2010. High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: Effects ofinsulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol. 4:706–716.
   PubMedGoogle Scholar
• Rydgren T, Sandler S. 2002. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1β-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. Eur J Endocrinol. 147:543–551.
   Google Scholar
• Saksida T, Stosic-Grujicic S, Timotijevic G, Sandler S, Stojanovic I. 2012. Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis. Immunol Cell Biol. 90:688–698.
   Google Scholar
• Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH. 1998. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA. 95:9558–9561.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. 2006. Inflammation and insulin resistance. J Clin Invest. 116:1793–1801.
   PubMed Web of Science ®Google Scholar
• Shulman GI. 2000. Cellular mechanisms of insulin resistance. J Clin Invest. 106:171–176.
   PubMed Web of Science ®Google Scholar
• Stojanovic I, Cvjeticanin T, Lazaroski S, Stosic-Grujicic S, Miljkovic D. 2009. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology. 126:74–83.
   PubMed Web of Science ®Google Scholar
• Stojanovic I, Saksida T, Stosic-Grujicic S. 2012. Beta cell function: The role of macrophage migration inhibitory factor. Immunol Res. 52:81–88.
   Google Scholar
• Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441–446.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. 2008. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 14:222–231.
   PubMed Web of Science ®Google Scholar
• Toso C, Serre-Beinier V, Emamaullee J, Merani S, Armanet M, Wojtusciszyn A, Bosco D, Calandra T, Roger T, Morel P, Shapiro AM, Berney T. 2008. The role of macrophage migration inhibitory factor in mouse islet transplantation. Transplantation. 86:1361–1369.
   PubMed Web of Science ®Google Scholar
• Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, van Erk M, de Vries-van der Weij J, Leng L, van Bockel JH, van Dijk KW, Fingerle-Rowson G, Bucala R, Kleemann R. 2009. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res. 105:99–107.
   PubMed Web of Science ®Google Scholar
• Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, Bucala R. 1997. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA. 94:4782–4787.
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest. 115:1111–1119.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yamagata K, Fukui K, Cao Y, Nammo T, Iwahashi H, Wang H, Matsumura I, Hanafusa T, Bucala R, Wollheim CB, Miyagawa J, Matsuzawa Y. 2002. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes. 51:1785–1792.
   PubMed Web of Science ®Google Scholar